Time to Buy Franklin MicroCap Value Advisor Fund (FVRMX)

FVRMX

Franklin MicroCap Value Advisor Fund (FVRMX - Free Report) seeks high total return, of which capital appreciation and income are components. FVRMX's managers invest primarily in the equity securities of companies with market capitalizations under $300 million, and focus on buying such securities when they are selling at a low price to book value.

This Small Cap Value product has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 8.2% and 5 year 11.9%. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.

The Franklin MicroCap Value Advisor fund, as of the last filing, allocates their fund in top one major group; Small Value. Further, as of the last filing, Healthcare Services Group Inc, Delta Apparel Inc and Hurco Companies Inc were the top holdings for FVRMX.

This Zacks Rank #2 (Buy) was incepted in December 1995 and is managed by Franklin/Temp. FVRMX carries an expense ratio of 0.95% and requires a minimal initial investment of $100,000.

Want key mutual fund info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>